Organization Announcements



Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

Paul G. Allen Frontiers Group [to 2 Oct 2021]
No new digest content identified.

BARDA – U.S. Department of HHS [to 2 Oct 2021]
No new digest content identified.

BMGF – Gates Foundation [to 2 Oct 2021]
Press Releases and Statements
No new digest content identified.

Bill & Melinda Gates Medical Research Institute [to 2 Oct 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X [to 2 Oct 2021]
07.29.2021  |
CARB-X celebrates five years of progress in early-stage product development against antibiotic-resistant bacteria
CARB-X, a global non-profit partnership led by Boston University, is celebrating five years of progress in funding and supporting the development of innovative products targeting antibiotic-resistant bacteria. Since it was founded in July 2016, CARB-X has invested $361 million in non-dilutive funding to develop innovative therapeutics including new classes of antibiotics and non-traditional agents, vaccines and other preventatives such as CRISPR-phage, microbiome-modifying agents and antibodies, and rapid diagnostics.

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 2 Oct 2021]
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – October 2021 is now posted here

CEPI – Coalition for Epidemic Preparedness Innovations [to 2 Oct 2021]
Latest News
No new digest content identified.

DARPA – Defense Advanced Research Projects Agency [to 2 Oct 2021
No new digest content identified.

Duke Global Health Innovation Center [to 2 Oct 2021]
Our Blog
What the Latest Global COVID-19 Summit Achieved (and missed)

EDCTP [to 2 Oct 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

Emory Vaccine Center [to 2 Oct 2021]
Vaccine Center News
No new digest content identified.

European Vaccine Initiative [to 2 Oct 2021]
Latest News
No new digest content identified.

Fondation Merieux [to 2 Oct 2021]
News, Events
No new digest content identified.

Gavi [to 2 Oct 2021]
News releases [See Milestones above for detail]
Gavi statement on the report of the independent commission on sexual exploitation and abuse
30 September 2021

Gavi Board meets to discuss routine immunisation, COVAX’s 2022 strategy
29 September 2021

Gavi progress report shows resilience in childhood vaccinations despite impact of COVID-19 pandemic
29 September 2021

GHIT Fund [to 2 Oct 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.

Global Fund [to 2 Oct 2021]
News & Stories
Global Fund Welcomes Netherlands New Contribution to the Global Fight Against COVID-19
01 October 2021
The Global Fund to Fight AIDS, Tuberculosis and Malaria welcomed the decision by the Netherlands to contribute an additional €15 million to the Global Fund’s COVID-19 Response Mechanism, on top of the €12 million committed in April 2021.

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 2 Oct 2021]
COVID-19: Advances and Remaining Challenges international conference opens September 29
Institut Pasteur will hold this international conference in collaboration with Inserm ANRS – Maladies infectieuses émergentes from September 29 to October 1, 2021. COVID-19 experts from around the globe will attend the event which will be broadcast live in English and held under the high patronage of the French President.
Leading researchers and clinicians will present the progress made and remaining challenges in virology, clinical presentations and management, epidemiology, and vaccinology for COVID-19. Topics to be covered include:
Viral entry and replication/neutralization
Viral persistence and Long COVID
Patient management and future treatments
Evaluation of impact of interventions
Children and SARS-CoV-2 transmission and control
Vaccine regimens and effectiveness
Why and how should we get the planet vaccinated?
Learn more & register

Hilleman Laboratories [to 2 Oct 2021]
Website reports “under maintenance” at inquiry

Human Vaccines Project [to 2 Oct 2021]
Sep 30, 2021
Salim Abdool Karim: The Broken System of Vaccine Distribution
Director of the Centre for the AIDS Program of Research, South Africa
Professor of Global Health, Columbia University

HVP Editor Kristen Jill Abboud recently spoke about the distribution of COVID vaccines in South Africa with Salim Abdool Karim, a clinical infectious disease epidemiologist who heads the Centre for the AIDS Program of Research in South Africa (CAPRISA) and is a Professor of Global Health at Columbia University in New York City. Karim also serves on the Lancet COVID-19 Commission and is the former chair of the South African Ministerial Advisory Committee on COVID-19. We discussed the early setbacks in the rollout of vaccines in South Africa and the lessons this pandemic offers for future global vaccine distribution.

IAVI [to 2 Oct 2021]
Latest News
September 30, 2021
IAVI applauds Biden Administration’s intent to nominate John Nkengasong as head of PEPFAR
Nkengasong was a founding leader of PEPFAR and has served on IAVI’s board since 2018.


International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.

ICRC [to 2 Oct 2021]
Selected News Releases, Statements, Reports
IHL App 2.0: International humanitarian law and more in your pocket
01-10-2021 | Article

DigitHarium Month #7: Biometrics and Humanitarian Protection
For the seventh DigitHarium month, we looked at how we can make biometric data work for humanitarian organizations: what they are, how they function, what advantages they present, and what mitigation measures we need to consider to make them safer to
01-10-2021 | Article

International Day for the Total Elimination of Nuclear Weapons Statement, September 2021
Mr President of the General Assembly, Mr Secretary-General, Distinguished Colleagues,I am pleased to mark this important event to commemorate the International Day for the Total Elimination of Nuclear Weapons.
30-09-2021 | Article

Joint Statement by the UN Resident and Humanitarian Coordinator and the Heads of ICRC, OCHA, UNICEF, and WHO in Afghanistan
In the meeting, we agreed to collaborate closely together and have committed our organizations to spare no effort in our joint objective to support the existing health system in Afghanistan to ensure all people have access to the healthcare they need
29-09-2021 | Statement


Press Releases/Announcements
No new digest content identified.

IFRC [to 2 Oct 2021]
Selected Press Releases, Announcements
COVID-19: IFRC calls for urgent action to tackle vaccine hesitancy in Europe amid increase in violent incidents
Budapest/Geneva, 30 September 2021 – The International Federation of Red Cross and Red Crescent Societies (IFRC) is calling for urgent action to tackle vaccine hesitancy in Europe, where there has been a worrying increase in violent incidents against COVID-19 related health infrastructure and personnel…
In addition, disinformation about vaccines’ side effects and potential risks, coupled with the introduction of ‘vaccine passes’, is sparking anger and violence, which have led to concerning incidents against medical services, media and the general public in countries including Italy, the Netherlands, the United Kingdom, Poland, Slovenia and France….

Afghanistan faces collapse of health services and mass hunger
… Speaking from Kabul where he has been on a four-day official visit, Alexander Matheou, IFRC Asia Pacific Director said: “After living through decades of fleeing and fighting, Afghans now face a severe drought which has devastated food production, leaving millions hungry and destitute. We are deeply concerned that Afghanistan faces imminent collapse of health services and worsening hunger if aid and money do not flow into the country within weeks. Health financing has been cut across the country placing ever more demand on Red Crescent teams. Urgent international action is needed to support millions of people with the necessities of life as Afghanistan’s looming harsh winter threatens greater misery and hardships.”…

IFRC launches emergency appeal to prepare for and respond to population movements from Afghanistan

Institut Pasteur [to 2 Oct 2021]
Press Documents
Press release
Covid-19: study on the effectiveness of immune memory after mRNA vaccination to recognize variants of SARS-CoV-2
The teams from Henri-Mondor AP-HP hospital and Paris-Est Créteil University, Inserm, CNRS, University of Paris, within the Necker-Enfants Malades Institute, and the Institut Pasteur analyzed the capacity of the immune memory generated after mRNA vaccination to recognize and neutralize SARS-CoV-2 variants.
This work, coordinated by Prof. Matthieu Mahévas, Dr Claude-Agnès Reynaud, Prof. Jean-Claude Weill, Dr Pascal Chappert, Dr Félix Rey and Dr Pierre Bruhns, shows that people vaccinated with a messenger RNA vaccine against SARS-CoV-2 develop defenses against the Beta and Delta variants. Their immune system indeed produces memory cells capable of recognizing and neutralizing these worrisome variants. The results of this study were published on September 20, 2021 in Immunity.

IOM / International Organization for Migration [to 2 Oct 2021]
News – Selected
30 Sep 2021
UN Agencies Call for Protection Measures and a Comprehensive Regional Approach for Haitians on the Move

ISC / International Science Council [to 2 Oct 2021]
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
News Press
Action for Afghan scientists and scholars
The InterAcademy Partnership (IAP) and the International Science Council (ISC) express concern for Afghan scholars in Afghanistan and around the world, and call for urgent action to preserve gains made in education and research in Afghanistan in recent decades.

Science in Exile podcast series launched
ISC Presents: Science in Exile features interviews with refugee and displaced scientists who share their science, their stories of displacement, and their hopes for the future. In the first episode, available now, Feras Kharrat shares his experiences as a scholar of molecular biomedicine, first in Syria, and now in Italy.

News Press
Gender Equality in Science: Inclusion and Participation of Women in Global Science Organizations
Results of two global surveys show women are still under-represented in world science. New report from the ISC, InterAcademy Partnership and Gender Insite released today.

IVAC [to 2 Oct 2021]
Updates; Events
No new digest content identified.

IVI [to 2 Oct 2021]
IVI News & Announcements
The International Vaccine Institute, Texas Children’s Hospital, and Baylor College of Medicine partner for collaborative vaccine research
Sept. 28, 2021 – SEOUL, South Korea, and HOUSTON, Texas, USA
…The collaboration is envisioned to include: (1) exchange of scientists between institutions; (2) collaborative research in vaccine development; (3) the sharing of scholarly and scientific materials, and (4) steps toward establishing an international collaborating office of IVI in a formal academic relationship with the Section of Pediatric Tropical Medicine in the Department of Pediatrics at Baylor…

Enrollment begins for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine candidate in Nepal, led by IVI
Sept. 28, 2021
…International Vaccine Institute (IVI) will lead the clinical trial in Nepal to assess the safety, efficacy and immunogenicity of an adjuvanted recombinant-protein COVID-19 vaccine candidate
Phase 3 international clinical trial includes volunteers from several countries, including sites in the US, Asia, Africa and Latin America…

IVI’s Statement for the Global COVID-19 Summit: Ending the Pandemic and Building Back Better
… To meet these goals, IVI is partnering with over 2 dozen organizations, from the laboratory through and beyond licensure, to move multiple COVID-19 vaccine candidates from testing to impact providing the kind of evidence that will inform better policy decisions on the use of vaccines and non-pharmacologic interventions…

Johns Hopkins Center for Health Security [to 2 Oct 2021]
Center News
25 Stakeholder Groups ask Congress to Support the $16 Billion Funding Level for Pandemic Preparedness Included in the Build Back Better Act Passed by the House Energy and Commerce Committee
September 28, 2021

MSF/Médecins Sans Frontières [to 2 Oct 2021]
Latest [Selected Announcements]
Medical care resumes in Tripoli detention centres
Project Update 29 Sep 2021

Tackling multidrug-resistant tuberculosis, one patient at a time
Project Update 29 Sep 2021

Northern Syria: Acute water crisis poses serious health risks
Project Update 29 Sep 2021

National Academy of Medicine – USA [to 2 Oct 2021]
Selected News/Programs
National Academy of Medicine Releases Video Encouraging Latinx/Latino(a)/Hispanic Americans to Accept the COVID-19 Vaccine
September 28, 2021
Today, the National Academy of Medicine (NAM) released a video encouraging Latinx/Latino(a)/ Hispanic Americans to get vaccinated for COVID-19. The video, which features 11 Latinx/Latino(a)/ Hispanic members of the NAM, highlights the safety and efficacy of the vaccines, reinforces their integral role in bringing families and communities back together safely, and features personal affirmations from the NAM […]

National Academy of Sciences – USA [to 2 Oct 2021]
No new digest content identified.

National Vaccine Program Office – U.S. HHS [to 2 Oct 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.

NIH [to 2 Oct 2021]
News Releases
NIAID issues new awards to fund “pan-coronavirus” vaccines
September 28, 2021 — The awards are intended to fuel vaccine research for a diverse family of coronaviruses, with a primary focus on potential pandemic-causing coronaviruses, such as SARS-CoV-2.
[See COVID – U.S. above for detail]

PATH [to 2 Oct 2021]
Press Releases
No new digest content identified.

Sabin Vaccine Institute [to 2 Oct 2021]
Statements and Press Releases
Commentary to the Global COVID-19 Summit: Ending the Pandemic and Building Back Better
September 15, 2021

UNAIDS [to 2 Oct 2021]
Selected Press Releases/Reports/Statements
1 October 2021
ArtPositive—art to raise awareness around HIV-related stigma and discrimination

29 September 2021
The first but not the last: Indonesian transgender man fights for recognition

28 September 2021
Launch of advocacy explainers on western Africa model drug law

UNHCR Office of the United Nations High Commissioner for Refugees [to 2 Oct 2021]
Selected News Releases, Announcements
UN agencies call for protection measures and a comprehensive regional approach for Haitians on the move
Joint statement by UNHCR, IOM, UNICEF, OHCHR
30 Sep 2021


Yemeni humanitarian organization wins 2021 UNHCR Nansen Refugee Award
UNHCR, the UN Refugee Agency, announces the winner of its 2021 Nansen Refugee Award. Five regional winners are also announced.
29 Sep 2021


News Comment: UNHCR echoes call for global action to resolve internal displacement
This news comment is attributable to Raouf Mazou, UNHCR’s Assistant High Commissioner for Operations
29 Sep 2021


UN: Syrian Refugees in Lebanon Struggle to Survive Amid Worst Socioeconomic Crisis in Decades
29 Sep 2021

UNICEF [to 2 Oct 2021]
Press Releases, News Notes, Statements [Selected]
UNICEF statement on Ethiopia
NEW YORK, 1 October 2021 – “The Ethiopian Government’s decision to expel the UNICEF representative in the country – along with other members of the UN leadership team – is regrettable and alarming.
“UNICEF has been present in Ethiopia for more than 60 years, working to advance and protect the rights of the most vulnerable children. As the humanitarian situation in the country deteriorates – with children bearing its biggest brunt – our work is more urgent than ever. We have full confidence in the teams working on the ground to save children’s lives, guided – as always – by the principles of impartiality, humanity, neutrality and independence. Our programmes will continue. Our one and only priority is to support the children who urgently need our help, wherever they are.”

Press release
Indonesia: More than 25,000 children orphaned due to COVID-19 since the start of the pandemic
UNICEF and partners call for greater support for families and surviving caregivers to ensure children remain in family-based care.
JAKARTA, 30 September 2021 – Since the start of the pandemic, 25,430 children in Indonesia have lost one or both caregivers due to COVID-19 according to a nationwide mapping by the Ministry of Women Empowerment and Child Protection (MoWECP) and UNICEF.
The mapping finds that the majority of children (57 per cent) have lost a male caregiver, over a third (37 per cent) have lost a female caregiver, and around five per cent have lost both caregivers. Most of the children are currently being looked after by a female caregiver, some by their extended families while 114 children are unaccompanied and are not being cared for by any adult.
The loss of one or both caregivers can have a detrimental impact on the nutrition, growth and development of children and can put them at greater risk of neglect, violence and exploitation – particularly infants and young children from low-income families. Children orphaned or bereft of their caregivers often face adverse consequences, including poverty and institutionalization.
The surviving or alternative caregivers also face additional economic and mental health burdens, which often fall on women and adolescent girls and may put them at increased risk of dropping out of school.
“We continue to monitor responses given to children whose parents died due to COVID-19 from all stakeholders,” said I. Gusti Ayu Bintang Darmawati, Minister of Women’s Empowerment and Child Protection. “We will make sure that these children are protected, and their rights can be fulfilled.”…

UN agencies call for protection measures and a comprehensive regional approach for Haitians on the move
Joint statement by UNHCR, IOM, UNICEF, OHCHR

Press release
EU Humanitarian Airbridge helps deliver 32 tonnes of UNICEF humanitarian supplies to Afghanistan

Remarks by UNICEF Executive Director Henrietta Fore at the launch of the Global Framework for United Nations Support on Syria/Iraq Third Country National Returnees

Unitaid [to 2 Oct 2021]
Featured News
Unitaid statement on molnupiravir as a treatment for mild and moderate COVID-19
Geneva, 1 October 2021 – Unitaid, on behalf of partners in the Access to COVID-19 Tools (ACT) Accelerator, welcomes today’s announcement on molnupiravir, an investigational oral antiviral medicine for treatment of mild and moderate COVID-19. Interim Phase 3 clinical trial results show that molnupiravir significantly reduced the risk of hospitalization or death from COVID-19 by approximately 50 percent when given in the early stages of infection.
“Effective, simple to use, oral treatments that can avert the progression to severe illness are exactly the kind of breakthroughs we need to get the pandemic under control. Deployed alongside vaccines, such medicines could drive down hospitalizations and deaths due to COVID-19,” said Dr Philippe Duneton, Executive Director of Unitaid.
Such a treatment could fundamentally change the response to the pandemic, enabling integrated test-and-care strategies when deployed together with appropriate diagnostic tests…

Statement in remembrance of Girindre Beeharry
Geneva, 30 September 2021 – I am deeply saddened by the passing of Girindre Beeharry, who represented the Bill and Melinda Gates Foundation on Unitaid’s Board, a position he held for several years. His memory remains very much alive. I would like to pay tribute to his clear-sightedness – the sharpness of his analyses went hand-in-hand with his humanity and his sense of humour. I wish to recognize and celebrate Girindre’s commitment to global public health. Through his unwavering dedication, he enabled Unitaid to move forward and find new solutions for people who need access to prevention, diagnostics, and treatments.
On behalf of everyone at Unitaid, our deepest sympathies and our most sincere condolences to Girindre’s family and to his daughter in particular.
Dr. Philippe Duneton, Executive Director, Unitaid

Vaccine Equity Cooperative [nee Initiative] [to 2 Oct 2021]
No new digest content identified.

Vaccination Acceptance & Demand Initiative [Sabin) [to 2 Oct 2021]
No new digest content identified.

Vaccine Confidence Project [to 2 Oct 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).

Vaccine Education Center – Children’s Hospital of Philadelphia [to 2 Oct 2021]
Feature Article — Guillain-Barré Syndrome (GBS) & Vaccines: The Risks and Recommendations
Published on Sep 14, 2021

Wellcome Trust [to 2 Oct 2021]
News and reports
No new digest content identified.

The Wistar Institute [to 2 Oct 2021]
Press Releases
No new digest content identified.

WFPHA: World Federation of Public Health Associations [to 2 Oct 2021]
Latest News
Eradicating Polio: What more Is Needed?
Sep 22, 2021
Polio cases have fallen 99.9% since 1988. In 2020 Africa was certified polio free by the World Health Organization. However, polio will remain a key public health concern until such time as there are no wild… On October 12, 2021, at 10:00 – 11:00 (CEST), “Eradicating Polio: What more Is Needed?” webinar will be held to focus on the barriers, challenges and leverages to reach every child and eradicate polio globally. Register

World Bank [to 2 Oct 2021]
Selected News, Announcements
The World Bank Provides US$ 500 Million to Strengthen Argentina’s COVID-19 Vaccination Plan
WASHINGTON D.C., October 1, 2021 – The World Bank Board of Directors today approved a US$500 million loan to strengthen Argentina’s efforts to contain the COVID-19 pandemic. The loan will be used to procure…
Date: October 01, 2021 Type: Press Release

Nigeria Scales Up its COVID-19 Vaccination with New Funding for Vaccine Purchase and Deployment
WASHINGTION, September 30, 2021 — The Government of Nigeria today received approval from The World Bank Board of Directors for a $400 million credit in additional financing from the International Development…
Date: September 30, 2021 Type: Press Release L

Development in a Time of Upheaval – World Bank Group President
Malpass outlines ways to boost growth, combat reversals in gender equality and human development, address rising inequality and climate change KHARTOUM, Sept. 30, 2021—World Bank Group President David…
Date: September 30, 2021 Type: Press Release

Development in a Time of Upheaval – Positioning Speech by World Bank Group President David Malpass
Watch the full recording of the speech.  Thank you, Prime Minister Hamdok for the warm introduction and hospitality. Ladies and gentlemen, it’s a great pleasure for me to be speaking today from Africa…
Date: September 30, 2021 Type: Speeches and Transcripts

US$100 Million to Support COVID-19 Vaccination in Iraq
BAGHDAD, September 28, 2021 — The World Bank has approved a new US$100 million project to scale up Iraq’s health sector response to the COVID-19 pandemic. The Iraq COVID-19 Vaccination Project will…
Date: September 28, 2021 Type: Press Release Language: English

World Customs Organization – WCO [to 2 Oct 2021]
Latest News – Selected Items
01 October 2021
Members of the WCO North of Africa, Near and Middle East (MENA) region discuss challenges and solutions in the cross-border e-commerce environment

World Organisation for Animal Health (OIE) [to 2 Oct 2021]
Press Releases, Statements
Enhancing veterinary laboratory capacity in COVID-19’s wake through the first-ever virtual OIE PVS mission
28 September 2021
The COVID-19 pandemic has marked a challenging but breakthrough moment for science, research and society at large. A cornerstone of human and animal health systems, laboratories across the world have seen the continuity of their operations put to the test. Their significant engagement to enhance capacity, to conduct research and to put equipment and expertise at the disposal of the larger health system, often meant that only critical diagnostic laboratory functions were maintained and ramped up, while other types of activities had to take a back seat. Travel restrictions made access to laboratory facilities limited or nearly impossible for external stakeholders, and essential quality assurance activities, such as audits and technical training, became difficult to implement. Among these challenges was the implementation of in-country missions by the World Organisation for Animal Health (OIE).

WTO – World Trade Organisation [to 2 Oct 2021]
WTO News and Events
No new digest content identified.


ARM [Alliance for Regenerative Medicine] [to 2 Oct 2021]
Selected Press Releases
No new digest content identified.

BIO [to 2 Oct 2021]
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.

DCVMN – Developing Country Vaccine Manufacturers Network [to 2 Oct 2021]
News; Upcoming events
No new digest content identified.

ICBA – International Council of Biotechnology Associations [to 2 Oct 2021]
No new digest content identified.

IFPMA [to 2 Oct 2021]
Selected Press Releases, Statements, Publications
African research foundation partners with international pharmaceutical industry to strengthen capacity for health innovation innovation in Africa
28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced today a three-year partnership to strengthen capacity for health innovation in Africa. The two organizations will combine forces to focus on driving capacity strengthening for drug discovery and development in Africa by scaling existing initiatives and identifying new development opportunities for young and mid-career scientists in the region.

The COVID-19 pandemic has highlighted the urgent need to bolster Africa’s ability, including its drug innovation capabilities, to face future health emergencies. Africa only conducts approximately 2 percent of world research on new infections, despite shouldering a quarter of the global disease burden[1]. While the continent is better prepared now to contribute to new healthcare threats as they emerge compared to a few decades ago, the disease focus remains narrow and is often not fully aligned with regional priorities. According to H3D-F, a foundation established to reduce barriers for health innovation and actively support African researchers and centers within the field of drug discovery and related sciences, the continent is primed for progress but requires an integrated health innovation ecosystem, investment in robust infrastructure, technology platforms, a critical mass of skilled talent, and job creation.

“The University of Cape Town Holistic Drug Discovery & Development (H3D) centre is the only integrated drug discovery and development platform in Africa. Over the last 10 years, it has proven itself as a platform to develop world class infrastructure, talent, and health innovation that will contribute to improving lives not only in Africa, but all over the world. We are ready to take our work to the next level through partnership and collaboration with key organizations like IFPMA, strengthening capacity far beyond H3D,” said Kelly Chibale, Chairman and CEO of H3D-F and Founder and Director of H3D.

Africa now hosts over 250 research sites and 73 vaccine clinical trials, but there are many gaps to fill[2]. For example, less than 10 universities provide vaccinology courses and only two local universities engage in vaccine-related pre-clinical studies[3]. IFPMA’s role is to be an anchor partner to provide short- to mid-term support in increasing awareness of H3D-F activities to develop and strengthen the capacity of human resources for health innovation in Africa. It will facilitate networking and visibility across the innovation ecosystem through its membership and offer opportunities for collaboration from drug development to market. Shared aims of the organizations are to call attention to drug innovation and access in the region – key pillars to achieving the sustainable development goals and universal health coverage…


International Generic and Biosimilar Medicines Association [IGBA]
No new digest content identified.

International Alliance of Patients’ Organizations – IAPO [to 2 Oct 2021]
Press and media [Selected]
No new digest content identified.

PhRMA [to 2 Oct 2021]
Latest News [Selected]
No new digest content identified.